{"id":321458,"date":"2026-10-21T17:27:43","date_gmt":"2026-10-21T11:57:43","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=321458"},"modified":"2026-10-21T17:27:43","modified_gmt":"2026-10-21T11:57:43","slug":"stocks-with-debt-to-equity-of-1-3-and-roe-above-15-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/stocks-with-debt-to-equity-of-1-3-and-roe-above-15-to-watch-multibagger-potential\/","title":{"rendered":"4 Top Stocks With Debt-to-Equity of 1-3 and ROE Above 15 to Watch for Future Multibagger Potential: M&M, Torrent Pharma, Narayana Health and Nuvama"},"content":{"rendered":"

M&M Rs 2,907. Torrent Pharma Rs 4,558.70. Narayana Health Rs 1,740.90. Nuvama Rs 1,683.80. Market caps from Rs 31,681 crore to Rs 3.48 lakh crore. Data as of 20 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

M&M, Torrent Pharma, Narayana Health and Nuvama are the 4 picks in this stocks with debt-to-equity of 1-3 and ROE above 15 watchlist, with market caps between Rs 31,681 crore and Rs 3.48 lakh crore. M&M stands out for the strongest latest-quarter profit growth at 37.04%, while Torrent Pharma offers the highest return on equity at 25.49%. PE ratios run from 17.19 to 81.26, so compare each one with its industry PE before investing. All figures are as of 20 October 2026.<\/p>\n<\/p><\/div>\n

Stocks with debt-to-equity of 1-3 and ROE above 15 to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. M&M, Torrent Pharma, Narayana Health and Nuvama meet that test, with market caps from Rs 31,681 crore to Rs 3.48 lakh crore and M&M offering the strongest latest-quarter profit growth at 37.04%. Each of these companies has a debt-to-equity ratio between 1 and 3 and a return on equity of at least 15 per cent, and net profit rose in FY26 and in the latest quarter.<\/p>\n

This list covers companies with a debt-to-equity ratio between 1 and 3 and a return on equity of at least 15 per cent, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. The companies here range from midcaps to largecaps in size. Investors screening stocks with debt-to-equity of 1-3 and ROE above 15 usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 20 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n